Home / Stocks / Indo Borax & Chemical Ltd
INDOBORAX

Indo Borax & Chemical Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹370.85

Change

-2.2 (-0.59%)

Open

₹374.9

Prev. Close

₹373.05

Day High

₹374.9

Day Low

₹369.0

Volume Analysis

Traded

12,212

Delivered

7,855

Delivery %

64.32%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (2)

  • •High debt-to-equity ratio (1.03)
  • •Promoter holding is falling

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹380.06 ₹377.48 ₹374.16 ₹371.58 ₹368.26 ₹365.68 ₹362.36
Fibonacci ₹377.48 ₹375.23 ₹373.83 ₹371.58 ₹369.33 ₹367.93 ₹365.68
Camarilla ₹372.47 ₹371.93 ₹371.39 ₹371.58 ₹370.31 ₹369.77 ₹369.23

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+36.74%

1 Week

-3.74%

1 Month

-12.15%

3 Months

-27.55%

6 Months

+14.94%

1 Year

+50.66%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹177.54

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

14.31%

Net margin 19.31% × asset turnover 0.3x × equity multiplier 2.47x

Company Overview

Sector

Chemicals

Market Cap

₹1,209 Cr

P/E (TTM)

28.5

ROE

10.1%

Book Value

₹89.4

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.

TopFund Analysis

Indo Borax & Chemical Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 52/100. The strongest factor is Cash Flow (75/100), while Growth (20/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (1.03); promoter holding is falling.

TopFund Score — Fundamentals Quality

52/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

57

Growth

20

Valuation

55

Cash Flow

75

Corporate Governance

50

Momentum

47

Institutional Ownership

30

Business Quality

71

Risk & Volatility

64

Liquidity

44

From Screener.in

  • +Debtor days have improved from 25.5 to 17.6 days.
  • −The company has delivered a poor sales growth of 8.37% over past five years.
  • −Company has a low return on equity of 12.2% over last 3 years.
  • −Company might be capitalizing the interest cost
  • −Promoters have pledged 100% of their holding.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

H1FY27 operating income rose 16% to Rs 129.29 crore; completed 64.26% Kronox acquisition and named Suresh Kalra MD/CEO.

Copies of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026 published in Free Press Journal and Navshakti

Board approved Q2 FY27 results; acquired 64.26% of Kronox Lab Sciences on 29 Sep 2026.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 47 44 45 50 38 38 50 54 58 41 63 70 59
Expenses + 37 35 34 33 29 27 40 41 47 32 50 51 57
Operating Profit 10 9 12 16 9 10 10 12 11 9 13 20 1
OPM % 21.71% 20.84% 25.45% 33.06% 24.19% 26.85% 20.35% 22.79% 18.15% 21.01% 20.35% 28.14% 2.51%
Other Income + 3 3 3 3 4 4 4 3 13 4 5 3 8
Interest 0 0 0 0 0 0 0 0 0 0 0 0 1
Depreciation 1 1 1 1 1 1 1 1 1 1 1 0 0
Profit before tax 12 11 14 19 13 14 13 14 23 12 17 22 8
Tax % 27.36% 27.49% 20.22% 27.03% 29.25% 33.75% 19.87% 29.02% 27.88% 23.72% 16.68% 26.09% 39.2%
Net Profit + 9 8 11 14 9 9 10 10 16 9 15 16 5
EPS in Rs 3 3 4 4 3 3 3 3 5 3 5 5 1
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -24 -20 -19 -9 -19 -15 10 8 53 9 26 31 2

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 87 70 67 101 128 115 144 176 225 191 175 215 233
Expenses + 69 57 56 83 108 97 100 128 163 149 129 171 191
Operating Profit 19 12 10 18 20 19 44 48 62 43 46 44 43
OPM % 21.0% 18.0% 15.0% 17.0% 16.0% 16.0% 31.0% 27.0% 28.0% 22.0% 26.0% 21.0% 18.0%
Other Income + 3 3 3 4 6 5 4 3 9 12 16 25 20
Interest 1 0 0 0 0 0 0 0 0 0 0 0 1
Depreciation 1 1 1 1 1 1 1 1 2 2 3 3 2
Profit before tax 20 14 12 20 24 22 47 50 69 52 59 67 59
Tax % 32.0% 32.0% 31.0% 34.0% 28.0% 24.0% 26.0% 27.0% 26.0% 25.0% 28.0% 24.0% —
Net Profit + 14 9 8 13 18 17 34 36 51 39 43 50 45
EPS in Rs 4 3 2 4 5 5 11 11 16 12 13 16 14
Dividend Payout % 4.0% 5.0% 6.0% 4.0% 3.0% 4.0% 9.0% 1.0% 6.0% 8.0% 8.0% 6.0% —
Sales growth 14 -20 -4 51 27 -10 25 22 28 -15 -8 23 17

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 75 84 91 101 118 135 170 204 252 290 332 383 284
Borrowings + 5 2 1 0 0 0 0 0 0 0 0 1 296
Other Liabilities + 9 8 10 12 11 10 17 14 20 18 21 17 126
Total Liabilities 92 97 106 117 132 149 190 222 275 311 357 405 708
Fixed Assets + 11 21 52 51 50 46 89 91 96 99 101 48 264
CWIP 2 2 1 1 1 1 1 1 1 1 1 1 3
Investments 14 32 23 20 37 18 30 4 9 43 57 209 14
Other Assets + 65 43 29 45 44 84 70 126 169 169 198 147 427
Total Assets 92 97 106 117 132 149 190 222 275 311 357 405 708
Equity Capital 3 3 3 3 3 3 3 3 3 3 3 3 3

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 0 18 21 1 15 13 16 11 60 69 -104 87
Cash from Investing Activity + 13 -26 -24 5 -16 26 -54 26 -8 -30 -7 -77
Cash from Financing Activity + -1 -4 -1 -2 -1 -1 -1 -3 -3 -3 -3 -3
Net Cash Flow 12 -12 -4 5 -2 38 -39 34 49 36 -115 7
Free Cash Flow -10 7 19 1 14 13 15 11 57 65 -111 106
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 38 186 226 37 111 100 61 54 123 197 -194 242

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 52.07% → 38.41%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 47.89% 49.09% 49.15% 49.14% 49.2% 49.16% 49.16% 48.67% 48.96% 66.56% 61.43% 61.45%
Promoters 52.07% 50.8% 50.79% 50.79% 50.79% 50.79% 50.79% 50.79% 50.79% 30.8% 38.41% 38.41%
FII 0.03% 0.1% 0.0% 0.06% 0.01% 0.02% 0.02% 0.53% 0.23% 0.45% 0.13% 0.1%
DII 0.0% 0.0% 0.06% 0.0% 0.0% 0.01% 0.02% 0.02% 0.02% 2.19% 0.04% 0.04%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Indo Borax & Chemical Ltd (this stock) 1,209 28.5 4.21 10.1%
Platinum Industries Ltd 1,208 26.0 2.62 12.7%
Astec Lifesciences Ltd 1,219 — 3.65 -25.2%
Ultramarine & Pigments L 1,192 11.9 1.35 8.59%
Excel Industries Ltd 1,246 15.8 0.6 4.62%
Spic Ltd 1,246 6.53 0.86 15.0%
India Pesticides Limited 1,333 14.1 1.28 12.5%

Which Mutual Funds Hold Indo Borax & Chemical Ltd?

Frequently Asked Questions about Indo Borax & Chemical Ltd

Community Sentiment

What are other investors saying about Indo Borax & Chemical Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.